These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 35450214)
1. The Value of Dysregulated LncRNAs on Clinicopathology and Survival in Non-Small-Cell Lung Wang J; Han X; Yuan Y; Gu H; Liao X; Jiang M Front Genet; 2022; 13():821675. PubMed ID: 35450214 [No Abstract] [Full Text] [Related]
2. Increased expression of lncRNA ZEB1-AS1 in non-small cell lung cancer is associated with poor prognosis. Xie J; Wu Y; Bian X; Chen D; Gui Q; Huang J Int J Clin Exp Pathol; 2018; 11(7):3703-3707. PubMed ID: 31949753 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis. Min SH; Zheng QQ Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNAs as potential biomarkers and therapeutic targets in gallbladder cancer: a systematic review and meta-analysis. Zhong Y; Wu X; Li Q; Ge X; Wang F; Wu P; Deng X; Miao L Cancer Cell Int; 2019; 19():169. PubMed ID: 31297033 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis. Zhang G; Cai J J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132 [TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis. Liu X; Huang G; Zhang J; Zhang L; Liang Z PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949 [TBL] [Abstract][Full Text] [Related]
7. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer. Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNAs function as novel predictors and targets of non-small cell lung cancer: a systematic review and meta-analysis. Xiong Y; Wang T; Wang M; Zhao J; Li X; Zhang Z; Zhou Y; Liu J; Jia L; Han Y Oncotarget; 2018 Feb; 9(13):11377-11386. PubMed ID: 29541420 [TBL] [Abstract][Full Text] [Related]
9. The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis. Tian T; Wang M; Lin S; Guo Y; Dai Z; Liu K; Yang P; Dai C; Zhu Y; Zheng Y; Xu P; Zhu W; Dai Z Mol Ther Nucleic Acids; 2018 Sep; 12():359-369. PubMed ID: 30195774 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis. Wang M; Ma X; Zhu C; Guo L; Li Q; Liu M; Zhang J Oncotarget; 2016 Dec; 7(49):81292-81304. PubMed ID: 27833074 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis. Chen X; Liang R; Lai L; Chen K; Zhu X Front Oncol; 2021; 11():697369. PubMed ID: 34490092 [TBL] [Abstract][Full Text] [Related]
12. The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant). Seyed Hosseini E; Nikkhah A; Sotudeh A; Alizadeh Zarei M; Izadpanah F; Nikzad H; Haddad Kashani H Cancer Cell Int; 2021 Aug; 21(1):447. PubMed ID: 34425840 [TBL] [Abstract][Full Text] [Related]
13. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis. Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909 [TBL] [Abstract][Full Text] [Related]
14. Abnormally expressed lncRNAs in the prognosis and clinicopathology of oesophageal cancer: a systematic review and meta-analysis. Qian P; Xu Z; Chen H; Yue S; Lv Y J Genet; 2020; 99():. PubMed ID: 32529986 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of long noncoding RNAs in non-small cell lung cancer: a meta-analysis. Jing W; Li N; Wang Y; Liu X; Liao S; Chai H; Tu J Oncotarget; 2017 Jan; 8(3):3957-3968. PubMed ID: 27992369 [TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis. Yang YL; Chen MW; Xian L PLoS One; 2014; 9(6):e99763. PubMed ID: 24978478 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases. Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690 [TBL] [Abstract][Full Text] [Related]
19. Association Between Efficacy of Immune Checkpoint Inhibitors and Sex: An Updated Meta-Analysis on 21 Trials and 12,675 Non-Small Cell Lung Cancer Patients. Xue C; Zheng S; Dong H; Lu X; Zhang X; Zhang J; Li J; Cui H Front Oncol; 2021; 11():627016. PubMed ID: 34513654 [TBL] [Abstract][Full Text] [Related]
20. LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis. Chen J; Chen Y; Gu L; Li X; Gao Y; Lyu X; Chen L; Luo G; Wang L; Xie Y; Duan J; Peng C; Ma X Oncotarget; 2016 Nov; 7(45):74325-74336. PubMed ID: 27527868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]